Countable Labs provides a PCR system for single-molecule counting and high-sensitivity molecular detection in biotechnology.
Countable Labs has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in May 2026.
Countable Labs's investors include Primer Ventures, ARCH Venture Partners, F-Prime.
Countable Labs is headquartered in Palo Alto, United States.
Countable Labs provides a PCR system for single-molecule counting and high-sensitivity molecular detection in biotechnology.
Countable Labs is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Countable Labs — Funding & Investors." VCBacked, May 28, 2026, https://www.vcbacked.co/company/countable-labs. Accessed September 30, 2026.
VCBacked. (2026). Countable Labs — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/countable-labs
{{cite web |title=Countable Labs — Funding & Investors |url=https://www.vcbacked.co/company/countable-labs |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated